“The ASHI meeting highlights scientific and medical advances in the fundamental understanding of transplantation as well as the unique collaborative and data sharing nature of the transplant community,” said John Sninsky, CSO.
Brisbane, California (PRWEB)
September 11, 2017
CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, will highlight CareDx’s Olerup pre-transplant diagnostic products at the 43rd Annual American Society for Histocompatibility & Immunogenetics (ASHI) which takes place September 11-15, 2017 in San Francisco, CA.
News for Olerup product portfolio at the meeting includes:
- Olerup QTYPE Speed and precision in HLA typing available on Roche LightCycler 480II, with additional platforms under development. Rapid typing is vital for deceased donor transplantation.
- Olerup SSP Continued HLA foundational typing with timely updates for new HLA alleles.
- Olerup SBT™ Accurate, gold standard sequence based typing (SBT) including reagents for sequencing, HARPS and software (Olerup Assign™ SBT). The SBT technology sets the benchmark for high-resolution HLA typing.
- CareDx will also host a symposium on September 12, 12:00–2:00 pm including presentations titled “QTYPE: Advancements in Rapid HLA Typing” Bruno Vanherberghen, PhD, Technical Brand Manager at CareDx. “Non-Invasive Rejection Monitoring for Thoracic Transplantation” Kiran K. Khush, MD, MAS, Associate Professor of Medicine, Stanford University; and “Clinical Utility of AlloSure, a Donor-Derived Cell-Free DNA test Validated in Kidney Transplantation” Robert N. Woodward, Ph.D., Senior Director, R&D at CareDx.
Abstract 419 (Poster P156) with co-authors from Children’s Hospital of Oakland Research Institute, Cornell University and Stanford University compares the HLA antigenic and immunogenic mismatches of transplant recipients and donors in a lung transplant study. Abstract 433 (Poster P140) indicates that the degree of HLA mismatch between donor and recipient does not confound measurement of donor-derived cell-free DNA (AlloSure).
The CareDx booth (#100) will highlight key innovations with a video on Olerup QTYPE and a…